G5S (p.Gly5Ser) variant of AGT (Angiotensinogen)

G5S (p.Gly5Ser) in AGT (Angiotensinogen) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Renal tubular dysgenesis of genetic origin; not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.15 / 1. The record also includes population frequency data and structural context.

G5S (p.Gly5Ser) variant details